Literature DB >> 22801983

Paediatric rheumatic disease: Biologic therapy and risk of infection in children with JIA.

Gerd Horneff.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22801983     DOI: 10.1038/nrrheum.2012.114

Source DB:  PubMed          Journal:  Nat Rev Rheumatol        ISSN: 1759-4790            Impact factor:   20.543


× No keyword cloud information.
  7 in total

1.  Etanercept in children with polyarticular juvenile rheumatoid arthritis. Pediatric Rheumatology Collaborative Study Group.

Authors:  D J Lovell; E H Giannini; A Reiff; G D Cawkwell; E D Silverman; J J Nocton; L D Stein; A Gedalia; N T Ilowite; C A Wallace; J Whitmore; B K Finck
Journal:  N Engl J Med       Date:  2000-03-16       Impact factor: 91.245

2.  Rates of malignancy associated with juvenile idiopathic arthritis and its treatment.

Authors:  Timothy Beukelman; Kevin Haynes; Jeffrey R Curtis; Fenglong Xie; Lang Chen; Christina J Bemrich-Stolz; Elizabeth Delzell; Kenneth G Saag; Daniel H Solomon; James D Lewis
Journal:  Arthritis Rheum       Date:  2012-02-10

Review 3.  The safety of anti-tumour necrosis factor therapy in rheumatoid arthritis.

Authors:  Johan Askling; Will Dixon
Journal:  Curr Opin Rheumatol       Date:  2008-03       Impact factor: 5.006

4.  Long-term safety and effectiveness of etanercept in children with selected categories of juvenile idiopathic arthritis.

Authors:  E H Giannini; N T Ilowite; D J Lovell; C A Wallace; C E Rabinovich; A Reiff; G Higgins; B Gottlieb; N G Singer; Y Chon; S-L Lin; S W Baumgartner
Journal:  Arthritis Rheum       Date:  2009-09

5.  Safety and efficacy of combination of etanercept and methotrexate compared to treatment with etanercept only in patients with juvenile idiopathic arthritis (JIA): preliminary data from the German JIA Registry.

Authors:  G Horneff; F De Bock; I Foeldvari; H J Girschick; H Michels; D Moebius; H Schmeling
Journal:  Ann Rheum Dis       Date:  2008-04-15       Impact factor: 19.103

6.  Adalimumab with or without methotrexate in juvenile rheumatoid arthritis.

Authors:  Daniel J Lovell; Nicolino Ruperto; Steven Goodman; Andreas Reiff; Lawrence Jung; Katerina Jarosova; Dana Nemcova; Richard Mouy; Christy Sandborg; John Bohnsack; Dirk Elewaut; Ivan Foeldvari; Valeria Gerloni; Jozef Rovensky; Kirsten Minden; Richard K Vehe; L Wagner Weiner; Gerd Horneff; Hans-Iko Huppertz; Nancy Y Olson; John R Medich; Roberto Carcereri-De-Prati; Melissa J McIlraith; Edward H Giannini; Alberto Martini
Journal:  N Engl J Med       Date:  2008-08-21       Impact factor: 91.245

7.  Rates of hospitalized bacterial infection associated with juvenile idiopathic arthritis and its treatment.

Authors:  Timothy Beukelman; Fenglong Xie; Lang Chen; John W Baddley; Elizabeth Delzell; Carlos G Grijalva; James D Lewis; Rita Ouellet-Hellstrom; Nivedita M Patkar; Kenneth G Saag; Kevin L Winthrop; Jeffrey R Curtis
Journal:  Arthritis Rheum       Date:  2012-08
  7 in total
  2 in total

Review 1.  Pediatric Inflammatory Multisystem Syndrome and Rheumatic Diseases During SARS-CoV-2 Pandemic.

Authors:  Adrien Schvartz; Alexandre Belot; Isabelle Kone-Paut
Journal:  Front Pediatr       Date:  2020-12-04       Impact factor: 3.418

2.  Negative effect of lockdown on juvenile idiopathic arthritis patients.

Authors:  Giovanni Conti; Francesca Galletta; Nicolina Stefania Carucci; Antonella La Mazza; Salvatore Antonio Mollica; Angela Alibrandi; Carmela Visalli
Journal:  Clin Rheumatol       Date:  2021-03-17       Impact factor: 2.980

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.